AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, will feature its complete suite of drug development and manufacturing solutions at INTERPHEX, April 2-4, at the Jacob Javits Center in New York, NY.
Additionally, the company will showcase its container closure integrity testing services offered through its Whitehouse Laboratories division.
With the release of the revised USP 1207 and pending Annex 1 revision, the adoption of more modern, deterministic, and comprehensive CCI programs is expanding. AMRI partners with clients to develop container system testing strategies that extend beyond CCI to encompass compendial testing, extractable and leachable studies, ISO device, delivery system testing, among other solutions.
AMRI representatives also will be on-hand at Booth 1830 to discuss the company’s global analytical, API and drug product solutions during the conference.
To arrange and schedule a meeting with AMRI (Booth No. 1830) while attending Interphex, please make a request here.